EA200600534A1 - COMBINATION OF SEROTONIN AND SEAMOXIN RETURN CAPTURE INHIBITOR - Google Patents
COMBINATION OF SEROTONIN AND SEAMOXIN RETURN CAPTURE INHIBITORInfo
- Publication number
- EA200600534A1 EA200600534A1 EA200600534A EA200600534A EA200600534A1 EA 200600534 A1 EA200600534 A1 EA 200600534A1 EA 200600534 A EA200600534 A EA 200600534A EA 200600534 A EA200600534 A EA 200600534A EA 200600534 A1 EA200600534 A1 EA 200600534A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- serotonin
- combination
- seamoxin
- inhibitor
- return capture
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title abstract 4
- 229940076279 serotonin Drugs 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 abstract 2
- 239000003772 serotonin uptake inhibitor Substances 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 208000027534 Emotional disease Diseases 0.000 abstract 1
- QWGDMFLQWFTERH-UHFFFAOYSA-N amoxapine Chemical compound C12=CC(Cl)=CC=C2OC2=CC=CC=C2N=C1N1CCNCC1 QWGDMFLQWFTERH-UHFFFAOYSA-N 0.000 abstract 1
- 229960002519 amoxapine Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение относится к применению сочетания амоксапина и ингибитора обратного захвата серотонина (SRI) или любого другого соединения, которое вызывает повышение уровня внеклеточного серотонина, для лечения депрессии и других эмоциональных нарушений.The present invention relates to the use of a combination of amoxapine and serotonin reuptake inhibitor (SRI) or any other compound that causes an increase in extracellular serotonin for the treatment of depression and other emotional disorders.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301269 | 2003-09-04 | ||
| PCT/DK2004/000580 WO2005023266A1 (en) | 2003-09-04 | 2004-09-01 | The combination of a serotonin reuptake inhibitor and amoxapine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200600534A1 true EA200600534A1 (en) | 2006-08-25 |
Family
ID=36319901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200600534A EA200600534A1 (en) | 2003-09-04 | 2004-09-01 | COMBINATION OF SEROTONIN AND SEAMOXIN RETURN CAPTURE INHIBITOR |
Country Status (6)
| Country | Link |
|---|---|
| KR (1) | KR20060072126A (en) |
| CN (1) | CN1845744A (en) |
| CA (1) | CA2537757A1 (en) |
| EA (1) | EA200600534A1 (en) |
| IS (1) | IS8299A (en) |
| ZA (1) | ZA200601463B (en) |
-
2004
- 2004-09-01 KR KR1020067004130A patent/KR20060072126A/en not_active Withdrawn
- 2004-09-01 CA CA002537757A patent/CA2537757A1/en not_active Abandoned
- 2004-09-01 EA EA200600534A patent/EA200600534A1/en unknown
- 2004-09-01 CN CNA2004800250891A patent/CN1845744A/en active Pending
- 2004-09-01 ZA ZA200601463A patent/ZA200601463B/en unknown
-
2006
- 2006-02-13 IS IS8299A patent/IS8299A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1845744A (en) | 2006-10-11 |
| ZA200601463B (en) | 2007-05-30 |
| KR20060072126A (en) | 2006-06-27 |
| CA2537757A1 (en) | 2005-03-17 |
| IS8299A (en) | 2006-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200601553A1 (en) | SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES | |
| CY1118007T1 (en) | METHODS FOR SUBSCRIBING SUBSCRIBERS | |
| CY1112238T1 (en) | ANTI-KINESIN SUSPENSIONS AND METHODS OF USING THESE | |
| MA30153B1 (en) | ANTI-OX40L ANTIBODIES AND CORRESPONDING METHODS | |
| UA87153C2 (en) | Enantiomerically Pure Aminogetroaryl Compounds as Protein kinase Inhibitors | |
| DE60327999D1 (en) | AZOLYLAMINOAZINES AS INHIBITORS OF PROTEIN KINASES | |
| EA200701918A1 (en) | PROTEIN LIPOKALIN | |
| CY1110046T1 (en) | GAVOXADOLI for the treatment of depression and other emotional disorders | |
| ATE526991T1 (en) | COMPOSITIONS AND THEIR USES FOR THE GENETHERAPEUTIC TREATMENT OF BONE DISEASES | |
| SE0301653D0 (en) | Novel compounds | |
| EA200401341A1 (en) | APPLICATION OF OSTEOPROTEGERIN FOR THE TREATMENT AND / OR PREVENTION OF FIBROUS DISEASE | |
| CL2007002380A1 (en) | Use of compounds derived from 2,5-dihydroxybenzene for the therapeutic and / or prophylactic treatment of actinic keratosis. | |
| EE05357B1 (en) | A tablet containing at least two distinct segments and its use | |
| NO20060242L (en) | The combination of a serotonin reuptake inhibitor and agomelatine | |
| UY28344A1 (en) | NEW COMPOUNDS | |
| EA200501528A1 (en) | APPLICATION OF CLUSTERIN FOR THE TREATMENT AND / OR PREVENTION OF PERIPHERAL NEUROLOGICAL DISEASES | |
| FI20031191A7 (en) | Monoamine reuptake inhibitor | |
| DE602004019541D1 (en) | CYCLOALKYLÄBÜ CONDENSED INDOLE | |
| CY1110368T1 (en) | SYNTHETIC COMBINATION THAT INCLUDES Roflumilast And (R, R) -formatoterol | |
| EA200801399A1 (en) | Substituted 5-heteroaryl-1-phenylpyrazole cannabinoid modulators | |
| ATE536874T1 (en) | TRIPLE MONOAMINE REUPPOST INHIBITORS FOR THE TREATMENT OF CHRONIC PAIN | |
| EA200800342A1 (en) | Glepp-1 INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE AND / OR INFLAMMATORY DISORDERS | |
| EA200600534A1 (en) | COMBINATION OF SEROTONIN AND SEAMOXIN RETURN CAPTURE INHIBITOR | |
| EA200600531A1 (en) | COMBINATION OF SEROTONIN AND LOXAPINE REVERSE CAPTURE INHIBITOR | |
| DK1455770T3 (en) | Use of norepinephrine uptake inhibitors for the treatment of tic disorders |